Vascular News and Research

RSS
Many Australians at risk of having a heart attack are not receiving the best possible care: Study

Many Australians at risk of having a heart attack are not receiving the best possible care: Study

The Transcatheter Cardiovascular Therapeutics 2009 to feature PLCs' RenalGuard System

The Transcatheter Cardiovascular Therapeutics 2009 to feature PLCs' RenalGuard System

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

Better visualization of soft tissues using Toshiba's LCI

Better visualization of soft tissues using Toshiba's LCI

CT-guided tube pericardiostomy, an effective treatment for pericardial effusion

CT-guided tube pericardiostomy, an effective treatment for pericardial effusion

KCI to conduct discussion on limb surgeries and amputations

KCI to conduct discussion on limb surgeries and amputations

NovoStent completes enrollment for its SAMBA Stent and Delivery System trial

NovoStent completes enrollment for its SAMBA Stent and Delivery System trial

Catheter for varicose vein treatment

Catheter for varicose vein treatment

Patient enrollment for PLATINUM workhorse trial completed by Boston Scientific

Patient enrollment for PLATINUM workhorse trial completed by Boston Scientific

Interim data from GORE PROPATEN Vascular Graft studies presented at the 2009 vascular meeting

Interim data from GORE PROPATEN Vascular Graft studies presented at the 2009 vascular meeting

Pervasis Therapeutics raises funds to support clinical development programs

Pervasis Therapeutics raises funds to support clinical development programs

NIH to fund grants for epigenetic research

NIH to fund grants for epigenetic research

Study focuses on hypertension

Study focuses on hypertension

Study: Therapy addition reduces risk of stroke and other cardiovascular events

Study: Therapy addition reduces risk of stroke and other cardiovascular events

Bioheart's MARVEL Phase II/III clinical trial successful

Bioheart's MARVEL Phase II/III clinical trial successful

New technique found that may prevent vision loss

New technique found that may prevent vision loss

Next Generation Advanced Image Processing for Toshiba Infinix-i product line

Next Generation Advanced Image Processing for Toshiba Infinix-i product line

Damaged heart tissue is significantly reduced with supersaturated oxygen

Damaged heart tissue is significantly reduced with supersaturated oxygen

DaVita achieves target fistula usage rate in Virginia

DaVita achieves target fistula usage rate in Virginia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.